MRK vs. PFE
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or PFE.
Correlation
The correlation between MRK and PFE is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. PFE - Performance Comparison
Key characteristics
MRK:
-1.38
PFE:
-0.32
MRK:
-1.86
PFE:
-0.30
MRK:
0.75
PFE:
0.97
MRK:
-0.86
PFE:
-0.13
MRK:
-1.65
PFE:
-0.63
MRK:
21.30%
PFE:
12.38%
MRK:
25.66%
PFE:
24.26%
MRK:
-68.62%
PFE:
-58.96%
MRK:
-38.54%
PFE:
-56.70%
Fundamentals
MRK:
$198.72B
PFE:
$127.78B
MRK:
$6.74
PFE:
$1.41
MRK:
11.68
PFE:
15.88
MRK:
0.72
PFE:
0.53
MRK:
3.10
PFE:
2.01
MRK:
4.28
PFE:
1.44
MRK:
$48.39B
PFE:
$48.75B
MRK:
$39.64B
PFE:
$31.22B
MRK:
$19.98B
PFE:
$12.18B
Returns By Period
In the year-to-date period, MRK achieves a -19.05% return, which is significantly lower than PFE's -12.72% return. Over the past 10 years, MRK has outperformed PFE with an annualized return of 7.14%, while PFE has yielded a comparatively lower 0.39% annualized return.
MRK
-19.05%
-9.14%
-23.33%
-35.27%
3.69%
7.14%
PFE
-12.72%
-10.84%
-17.89%
-7.85%
-4.33%
0.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. PFE — Risk-Adjusted Performance Rank
MRK
PFE
MRK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. PFE - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.96%, less than PFE's 7.42% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.96% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
PFE Pfizer Inc. | 7.42% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Drawdowns
MRK vs. PFE - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for MRK and PFE. For additional features, visit the drawdowns tool.
Volatility
MRK vs. PFE - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 10.96% compared to Pfizer Inc. (PFE) at 10.19%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities